CoChat

Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses

Open access
Gao, Zhenxiang, Winhusen, T. John, Gorenflo, Maria, Ghitza, Udi E., Davis, Pamela B., Kaelber, David C., Xu, Rong · 2023 · Addiction
Cited by 40

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background and aims: Cocaine use disorder (CUD) is a significant public health issue for which there is no Food and Drug Administration (FDA) approved medication. Drug repurposing looks for new cost‐effective uses of approved drugs. This study presents an integrated strategy to identify repurposed FDA‐approved drugs for CUD treatment. Design: Our drug repurposing strategy combines artificial intelligence (AI)‐based drug prediction, expert panel review, clinical corroboration and mechanisms of action analysis being implemented in the National Drug Abuse Treatment Clinical Trials Network (CTN). Based on AI‐based prediction and expert knowledge, ketamine was ranked as the top candidate for clinical corroboration via electronic health record (EHR) evaluation of CUD patient cohorts prescribed ketamine for anesthesia or depression compared with matched controls who received non‐ketamine anesthesia or antidepressants/midazolam. Genetic and pathway enrichment analyses were performed to understand ketamine’s potential mechanisms of action in the context of CUD. Setting: The study utilized TriNetX to access EHRs from more than 90 million patients world‐wide. Genetic‐ and functional‐level analyses used DisGeNet, Search Tool for Interactions of Chemicals and Kyoto Encyclopedia of Genes and Genomes databases. Participants: A total of 7742 CUD patients who received anesthesia (3871 ketamine‐exposed and 3871 anesthetic‐controlled) and 7910 CUD patients with depression (3955 ketamine‐exposed and 3955 antidepressant‐controlled) were identified after propensity score‐matching. Measurements: EHR analysis outcome was a CUD remission diagnosis within 1 year of drug prescription. Findings: Patients with CUD prescribed ketamine for anesthesia displayed a significantly higher rate of CUD remission compared with matched individuals prescribed other anesthetics [hazard ratio (HR) = 1.98, 95% confidence interval (CI) = 1.42–2.78]. Similarly, CUD patients prescribed ketamine for depression evidenced a significantly higher CUD remission ratio compared with matched patients prescribed antidepressants or midazolam (HR = 4.39, 95% CI = 2.89–6.68). The mechanism of action analysis revealed that ketamine directly targets multiple CUD‐associated genes (BDNF, CNR1, DRD2, GABRA2, GABRB3, GAD1, OPRK1, OPRM1, SLC6A3, SLC6A4) and pathways implicated in neuroactive ligand‐receptor interaction, cAMP signaling and cocaine abuse/dependence. Conclusions: Ketamine appears to be a potential repurposed drug for treatment of cocaine use disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/add.16168

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 40

Metadata

Authors
Gao, Z., Winhusen, T. J., Gorenflo, M., Ghitza, U. E., Davis, P. B., Kaelber, D. C., & Xu, R.
Venue
Addiction
Publisher
Wiley
Published
2023-02-23
Volume
118
Issue
7
Pages
1307-1319
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W4320879294
Cited by
40
References
17
FWCI
6.69
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses. https://app.cochat.ai/papers/10.1111/add.16168
The paper
Gao, Z., Winhusen, T. J., Gorenflo, M., Ghitza, U. E., Davis, P. B., Kaelber, D. C., & Xu, R. (2023). Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses. Addiction. https://doi.org/10.1111/add.16168

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.